La. Kane et al., FAMILIAL MEDULLARY-THYROID CANCER AND PROMINENT CORNEAL NERVES - CLINICAL AND GENETIC-ANALYSIS, The Journal of clinical endocrinology and metabolism, 80(1), 1995, pp. 289-293
A unique kindred manifesting medullary thyroid carcinoma and corneal n
erve thickening without other aspects of the multiple endocrine neopla
sia syndrome (MEN) was analyzed by linkage analysis using four highly
polymorphic (CA)(n) repeat markers (sTCL-1, D10S141, ZNF22, and sJRH-1
). Additionally, the RET protooncogene was examined for specific mutat
ions by DNA sequence analyses in all affected family members. Screenin
g of 11 family members spanning 4 generations revealed 7 subjects with
corneal nerve thickening; of these subjects, 3 had abnormal pentagast
rin-stimulated calcitonin studies, and these 3 subjects were each foun
d to have C-cell hyperplasia or medullary thyroid carcinoma at surgery
. Linkage analysis showed cosegregation of alleles (as defined by the
above markers), with the presence of both corneal nerve thickening and
medullary thyroid carcinoma/C-cell hyperplasia (maximum LOD score, 2.
69; consistent with, but not proving Linkage). DNA sequence analysis s
howed that none of the affected individuals had mutations in either ex
on 10 or 11, or in exon 16 of the RET protooncogene, regions where mut
ations have been described for MEN type 2A (MEN-2A) and MEN-SB familie
s, respectively. Thus, compared to the defined syndromes of MEN-2A and
MEN-2B, this kindred appears to represent a true clinical overlap syn
drome whose genetic basis may be distinct fi om these two syndromes.